Quick Answer
Aptose Biosciences Inc. reported Net Income of -$25.47 million for fiscal year 2025.
Aptose Biosciences Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$25.47M | -0.1% |
| 2024 | -$25.43M | +50.3% |
| 2023 | -$51.21M | -22.4% |
| 2022 | -$41.82M | +36.0% |
| 2021 | -$65.35M | -18.3% |
| 2020 | -$55.24M | -110.2% |
| 2019 | -$26.28M | +9.0% |
| 2018 | -$28.87M | -147.9% |
| 2017 | -$11.64M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$5.12M | +26.3% | +27.3% |
| June 30, 2025 | -$7.04M | +2.9% | -27.1% |
| March 31, 2025 | -$5.54M | +42.5% | +20.3% |
| September 30, 2024 | -$6.95M | +39.3% | +4.1% |
| June 30, 2024 | -$7.25M | +48.7% | +24.8% |
| March 31, 2024 | -$9.64M | +29.5% | +15.8% |
| September 30, 2023 | -$11.45M | -17.1% | +19.0% |
| June 30, 2023 | -$14.13M | -33.7% | -3.3% |
- Aptose Biosciences Inc. showed a decrease of -0.1% in Net Income compared to the prior fiscal year.
- Over the 2017–2025 period, Aptose Biosciences Inc.’s net income has declined by 118.7% (from -$11.64 million to -$25.47 million).
- The most recent figure is from Aptose Biosciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: